Xin Lang Cai Jing·2026-02-10 06:44Core Viewpoint - Shanghai Pharmaceuticals Holding Co., Ltd. has been awarded the title of "Advanced Collective in Industrial Economic Operation" by the Shanghai Municipal Economic and Information Commission, marking its third consecutive year of receiving this honor, which highlights the company's leading role and continuous contribution to the city's industrial growth [1][5]. Group 1 - In 2025, Shanghai Pharmaceuticals is committed to implementing the decisions of the municipal government, taking on the responsibility of a "chain leader" enterprise, and promoting stable growth, innovation, and transformation in the pharmaceutical industry [1][5]. - The company has successfully launched a Class 1 new drug through independent research and development, enhancing its original innovation capabilities and contributing significantly to the stable operation of the city's industrial economy and the high-quality development of the biopharmaceutical industry [1][5]. - The Shanghai Municipal Science and Technology Commission has recognized Shanghai Pharmaceuticals and its seven subsidiaries for their outstanding contributions to the high-quality development of the biopharmaceutical industry [1][5]. Group 2 - The Shanghai Municipal Economic and Information Commission has acknowledged Shanghai Pharmaceuticals as a leading enterprise in the city's biopharmaceutical industry, emphasizing its significant achievements in production stability, structural optimization, and innovation-driven initiatives [3][8]. - The commission encourages the company to maintain its exemplary role in cost reduction, talent motivation, and high-end manufacturing to provide solid support for the city's industrial growth [3][8]. - The Shanghai Municipal Science and Technology Commission noted that the growth rate of Shanghai's biopharmaceutical industry in 2025 exceeded the national average, with Shanghai Pharmaceuticals playing a crucial role in this achievement [3][8]. Group 3 - The recognition received by Shanghai Pharmaceuticals serves as both affirmation and motivation, prompting the company to aim for the goal of becoming a world-class pharmaceutical industry group led by technological innovation [5][10]. - The company plans to leverage its integrated advantages in industry, commerce, research, and investment, deepen industry chain collaboration, and accelerate AI empowerment and digital transformation [5][10]. - Shanghai Pharmaceuticals is committed to fulfilling its mission as a state-owned leading enterprise and contributing to the establishment of a world-class biopharmaceutical industry cluster in Shanghai [5][10].